References
- Davies B, Morris T. 1993. Physiological-parameters in laboratory-animals and humans. Pharm Res. 10(7):1093–1095. doi: 10.1023/a:1018943613122.
- Ellis LC, Hawksworth GM, Weaver RJ. 2013. ATP-dependent transport of statins by human and rat MRP2/Mrp2. Toxicol Appl Pharmacol. 269(2):187–194. doi: 10.1016/j.taap.2013.03.019.
- Fardel O, Moreau A, Le Vee M, Denizot C, Parmentier Y. 2019. Evaluation of drug biliary excretion using sandwich-cultured human hepatocytes. Eur J Drug Metab Pharmacokinet. 44(1):13–30. doi: 10.1007/s13318-018-0502-x.
- Hirata Y, Ikeda K, Sudoh M, Tokunaga Y, Suzuki A, Weng L, Ohta M, Tobita Y, Okano K, Ozeki K, et al. 2012. Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis. PLOS Pathog. 8(8):e1002860. doi: 10.1371/journal.ppat.1002860.
- Horiuchi S, Kuroda Y, Oyafuso R, Komizu Y, Takaki T, Maeda K, Ishida S. 2022. Construction of a culture protocol for functional bile canaliculi formation to apply human iPS cell-derived hepatocytes for cholestasis evaluation. Sci Rep. 12(1):15192. doi: 10.1038/s41598-022-19469-x.
- Ito S, Kusuhara H, Yokochi M, Toyoshima J, Inoue K, Yuasa H, Sugiyama Y. 2012. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney. J Pharmacol Exp Ther. 340(2):393–403. doi: 10.1124/jpet.111.184986.
- Katsume A, Tokunaga Y, Hirata Y, Munakata T, Saito M, Hayashi H, Okamoto K, Ohmori Y, Kusanagi I, Fujiwara S, et al. 2013. A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes. Gastroenterology. 145(4):865–873. doi: 10.1053/j.gastro.2013.06.012.
- Kawai R, Mathew D, Tanaka C, Rowland M. 1998. Physiologically based pharmacokinetics of cyclosporine A: extension to tissue distribution kinetics in rats and scale-up to human. J Pharmacol Exp Ther. 287(2):457–468.
- Kitaguchi T, Horiuchi S, Kuroda Y, Ohno K, Kobayashi K, Tanaka M, Ishida S. 2023. Construction of extended and functional bile canaliculi using long-term sandwich-cultured cryopreserved human hepatocytes and the application of hepatocytes for predicting the biliary excretion of pharmaceutical and food-related compounds. J Toxicol Sci. 48(5):251–261. doi: 10.2131/jts.48.251.
- Liao M, Zhu Q, Zhu A, Gemski C, Ma B, Guan E, Li AP, Xiao G, Xia CQ. 2019. Comparison of uptake transporter functions in hepatocytes in different species to determine the optimal model for evaluating drug transporter activities in humans. Xenobiotica. 49(7):852–862. doi: 10.1080/00498254.2018.1512017.
- Matsushima S, Maeda K, Kondo C, Hirano M, Sasaki M, Suzuki H, Sugiyama Y. 2005. Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein. J Pharmacol Exp Ther. 314(3):1059–1067. doi: 10.1124/jpet.105.085589.
- Murakata M, Ikeda T. 2017. Stereoselective synthesis of the viridiofungin analogue NA808 from a chiral tetrahydrofuran-carboxylic acid. Org Biomol Chem. 15(31):6632–6639. doi: 10.1039/c7ob01608e.
- Nishiyama K, Toshimoto K, Lee W, Ishiguro N, Bister B, Sugiyama Y. 2019. Physiologically-based pharmacokinetic modeling analysis for quantitative prediction of renal transporter-mediated interactions between metformin and cimetidine. CPT Pharmacometrics Syst Pharmacol. 8(6):396–406. doi: 10.1002/psp4.12398.
- Sasaki M, Suzuki H, Ito K, Abe T, Sugiyama Y. 2002. Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and Multidrug resistance-associated protein 2 (MRP2/ABCC2). J Biol Chem. 277(8):6497–6503. doi: 10.1074/jbc.M109081200.
- Sun P, Wang C, Liu Q, Meng Q, Zhang A, Huo X, Sun H, Liu K. 2014. OATP and MRP2-mediated hepatic uptake and biliary excretion of eprosartan in rat and human. Pharmacol Rep. 66(2):311–319. doi: 10.1016/j.pharep.2014.02.013.
- Watanabe T, Kusuhara H, Maeda K, Shitara Y, Sugiyama Y. 2009. Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans. J Pharmacol Exp Ther. 328(2):652–662. doi: 10.1124/jpet.108.146647.